The Competition Commission of India closed a decade-old case against twelve Delhi-NCR super-speciality hospitals over alleged overcharging on rooms, tests, devices, consumables and medicines. Disagreeing with its Director General, the Commission rejected a per-hospital market and found no abuse of a dominant position under Section 4.